Filters

ANKRD32 Antibody

ANKRD32 Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameANKRD32 Primary Polyclonal Antibody
Also known asANKRD32 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenANKRD32
SpecificityThis is a highly specific antibody against ANKRD32
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ANKRD32
Gene ID number84250
Tested Applications IF(IHC-P), IHC-P
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigenANKRD32
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names ANR32_HUMAN, Ankrd32, Ankyrin repeat domain-containing protein 32, BRCT domain-containing protein 1, Brctd1, Brctx
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetANKRD32
Short nameANKRD32 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameANKRD32 (Antibody to)
Alternative techniqueantibodies
Identity 25408
Gene SLF1
Long gene name SMC5-SMC6 complex localization factor 1
Synonyms gene BRCTD1 ANKRD32
Synonyms gene name BRCT domain containing 1 ankyrin repeat domain 32
Synonyms DKFZp761C121 DKFZp564C0469 BRCTx
Locus 5q15
Discovery year 2004-06-04
GenBank acession AL136560
Entrez gene record 84250
Pubmed identfication 15632077 25931565
RefSeq identity NM_032290
Classification Ankyrin repeat domain containing
Havana BLAST/BLAT OTTHUMG00000121133

Subscribe to our Newsletter